HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 31,050
-900 (-2.82%)
Sep 22, 2026, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 4.25 trillion as of September 21, 2026. Its market cap has decreased by -18.13% in one year.
Market Cap
4.25T
Enterprise Value
4.68T
Revenue
97.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
31,050.00
ChartMarket Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 4.25T, an increase of 31,457.54%. That is a compound annual growth rate of 38.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 4.25T | -36.46% |
| Dec 30, 2025 | 6.69T | -30.26% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 8.12T |
| SK Biopharmaceuticals | 6.08T |
| Peptron | 3.64T |
| ABL Bio | 3.14T |
| LigaChem Biosciences | 3.03T |
| SK bioscience | 2.74T |
| OliX Pharmaceuticals | 2.54T |
| Voronoi | 2.38T |